B-lymphocyte targeting agents for use in a method for the treatment of a disease

Details for Australian Patent Application No. 2010237272 (hide)

Owner Charite - Universitatsmedizin Berlin

Inventors Tschope, Carsten; Schultheiss, H.-P.; Escher, Felicitas; Volk, Hans-Dieter; Reinke, Petra

Agent Allens Arthur Robinson

Pub. Number AU-A-2010237272

PCT Pub. Number WO2010/118890

Priority 09005424.8 16.04.09 EP

Filing date 16 April 2010

Wipo publication date 21 October 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

10 November 2011 PCT application entered the National Phase

  PCT publication WO2010/118890 Priority application(s): WO2010/118890

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010237302-Novel P2X7R antagonists and their use

2010237271-Synthesis of 1-amino-1,3,3,5,5-pentamethylcyclohex ane mesylate